You are here

cilta-cel

Legend Biotech to Showcase Leadership in Multiple Myeloma Treatment at the ASH 2023 Annual Meeting

BioSpace

Thu, 11/2/23 - 11:36 am

Multiple Myeloma

Legend Biotech Achieves Milestone Under Collaboration Agreement with Janssen Biotech, Inc. for BCMA CAR-T

BioSpace

Thu, 04/21/22 - 10:57 am

FDA pushes back decision on J&J, Legend's BCMA CAR-T

Endpoints

Tue, 11/2/21 - 10:42 am

Go or go go? J&J’s cell therapy heads to the FDA

EP Vantage

Fri, 10/29/21 - 10:33 am

Multiple Myeloma

FDA sets November review date for J&J’s multiple myeloma CAR-T cilta-cel

Pharmaforum

Thu, 05/27/21 - 11:59 pm

Multiple Myeloma

Janssen flags accelerated approval milestone in Europe for CAR-T therapy

Biopharma Reporter

Mon, 02/1/21 - 11:04 pm

Chasing BMS, J&J files BCMA CAR-T for multiple myeloma to FDA

Pharmaforum

Tue, 12/22/20 - 10:41 am

Multiple Myeloma

Bristol-Myers Squibb